With General Data Protection Regulations (GDPR) compliance rollouts largely complete worldwide, Enterprise Content Management (ECM) vendors are shifting from security and privacy priorities toward machine learning and AI for tighter integration, the ECM Value Matrix 2019 shows. Leading vendors are pivoting to integration between independent applications, optical character recognition for more efficient data capture, collaboration tools, and the extension of AI and machine learning (ML) technologies to help organizations derive more value from their data.
ECM Technology Value Matrix Leaders include: Box, Laserfiche, M-Files, Nuxeo, and OpenText
This year user feedback has been radically different, leading with AI and machine learning, automation, integration, capture, and collaboration. Users stated that although security is still on their radar, they now expect vendors to deliver secure products and are more concerned with innovation as a differentiator, said Barbara Peck, principal analyst at Nucleus Research.
Nucleus predicts traditional monolithic ECM vendors will continue to fade as buyers look for usability, functionality and innovation “ rather than reputation “ when selecting content management and collaboration platforms. Some mature vendors will remain, but wont be expanding their market position, as customers look for offerings that deliver an integrated view of content management spanning the lifecycle of a document from inception to archiving.
See the full report at: https://nucleusresearch.com/research/single/ecm-technology-value-matrix-2019/
WANT TO BUILD A FINANCIAL EMPIRE?
Subscribe to the Global Banking & Finance Review Newsletter for FREE Get Access to Exclusive Reports to Save Time & Money
By using this form you agree with the storage and handling of your data by this website. We Will Not Spam, Rent, or Sell Your Information.
About Nucleus Research
Nucleus Research is a global provider of investigative, case-based technology research and advisory services. We deliver the numbers that drive business decisions. For more information, visit NucleusResearch.com or follow us on Twitter @NucleusResearch.
(917) 324 0808